Nuvectis Pharma, Inc. (NVCT) Tops Q1 EPS by 15c

Nuvectis Pharma, Inc. (NASDAQ: NVCT) reported Q1 EPS of ($0.25), $0.15 better than the analyst estimate of ($0.40).

For earnings history and earnings-related data on Nuvectis Pharma, Inc. (NVCT) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Terra Innovatum Global N.V. (NKLR) Misses Q2 EPS by 12c
• GLJ Research on Sell Rated Tesla (TSLA): 'We now see FSD as the main reason TSLA’s stock will bleed lower this year'